Skip to main content
Shanghai Kindly Enterprise Development Group Co.,Ltd. logo

Shanghai Kindly Enterprise Development Group Co.,Ltd. — Investor Relations & Filings

Ticker · 603987 ISIN · CNE100003076 LEI · 3003003G07QZESUB1P38 Shanghai Stock Exchange Manufacturing
Filings indexed 1,380 across all filing types
Latest filing 2022-07-06 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 603987

About Shanghai Kindly Enterprise Development Group Co.,Ltd.

https://www.kindly-group.com/

Shanghai Kindly Enterprise Development Group Co., Ltd. specializes in the research, development, and manufacturing of medical puncture instruments and related consumables. The company's product portfolio includes a wide range of hypodermic needles, syringes, infusion sets, and blood collection devices. KDL also produces specialized medical components such as insulin needles, dental needles, and aesthetic medical instruments. With a focus on precision engineering and high-quality standards, the group serves a global market, providing essential medical supplies to healthcare facilities and distributors. The company maintains a comprehensive production chain from raw materials to finished products, ensuring consistency and safety in clinical applications.

Recent filings

Filing Released Lang Actions
上海康德莱企业发展集团股份有限公司关于调整回购股份价格上限的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the adjustment of the upper limit of the share repurchase price. It details the board meeting decision to increase the maximum repurchase price per share from 18.68 RMB to 25 RMB, explains the rationale, legal compliance, and impact on the company and shareholders. The document does not contain financial statements or detailed financial data but is a formal disclosure about a change in the share buyback plan. This fits the definition of a Transaction in Own Shares (POS) filing, which covers announcements about the company buying back its own shares or changes to share repurchase plans.
2022-07-06 Chinese
上海康德莱企业发展集团股份有限公司独立董事关于第四届董事会第二十二次会议相关事项发表的独立意见
Regulatory Filings
2022-07-06 Chinese
上海康德莱企业发展集团股份有限公司关于收到上海证券交易所对上海康德莱企业发展集团股份有限公司重大资产不再纳入合并范围报告书(草案)信息披露的问询函的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding a query letter received from the Shanghai Stock Exchange about the company's major asset restructuring report draft. The content focuses on the inquiry about the company's disclosure and explanation related to a significant asset no longer being consolidated in the financial statements. It does not contain actual financial statements or detailed financial data but is rather a regulatory announcement responding to a regulatory inquiry. The document length is short (1412 characters), and it primarily serves as a disclosure announcement about the inquiry and the company's commitment to respond. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-07-06 Chinese
上海康德莱企业发展集团股份有限公司关于控股股东非公开发行可交换公司债券调整换股价格的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding an adjustment to the exchange price of a non-publicly issued exchangeable corporate bond by the controlling shareholder. It details the bond issuance, the adjustment formula for the exchange price due to dividend distribution, and the new adjusted exchange price. The document is short (1229 characters) and focuses on a specific financing instrument and its price adjustment, which is a capital structure update. There is no comprehensive financial report or earnings data, nor is it a regulatory certification or voting result. Therefore, this fits best under Capital/Financing Update (CAP).
2022-07-01 Chinese
上海康德莱企业发展集团股份有限公司关于本次重大资产重组事项相关财务数据延期的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the delay in the validity period of financial data related to a major asset restructuring. It discusses the reasons for the delay, including the impact of the COVID-19 pandemic, and references regulatory notices from Chinese authorities about extending deadlines for financial data validity and shareholder meeting notices. The document does not contain actual financial statements or detailed financial analysis but is an update on the timing and procedural aspects of the restructuring process. It is essentially a regulatory announcement about the extension of financial data validity deadlines related to a major asset restructuring, not the restructuring report itself or detailed financial data. The document length is short (1742 characters), and it serves as a formal announcement of a procedural update rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-06-30 Chinese
重组报告书独立财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor Verification Opinion Form" related to a major asset restructuring of Shanghai Kangdelai Enterprise Development Group Co., Ltd. It discusses the details of a significant asset reorganization, including control changes, compliance with laws and regulations, and the impact on the company's financials. The document is a detailed verification and opinion report by an independent financial advisor regarding a major asset restructuring event. It is not a full annual or interim report, nor is it a simple announcement or certification. It contains substantive financial and operational analysis related to a major asset restructuring. Therefore, it fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to significant corporate events such as major asset restructurings. FY 2021
2022-06-29 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.